C4 Therapeutics Inc Long-term Investment Intensity
C4 Therapeutics Inc long-term investment intensity. C4 Therapeutics Inc (CCCC) has a Long-term Investment Intensity of 13.0% as of June 2026. Long-term investments of $46.79 Million represent 13.0% of total assets of $359.40 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See C4 Therapeutics Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of C4 Therapeutics Inc (2021–2025)
Long-term investment intensity of C4 Therapeutics Inc from 2021 to 2025. This chart shows how C4 Therapeutics Inc's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 13.0%, reflecting long-term investments of $46.79 Million against total assets of $359.40 Million USD. See CCCC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
C4 Therapeutics Inc Long-term Investment Intensity by Year (2021–2025)
C4 Therapeutics Inc long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for C4 Therapeutics Inc from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of C4 Therapeutics Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 13.5% | $48.56 Million | $359.07 Million | ▲ +7.1 pp |
| 2024 | 6.4% | $22.36 Million | $349.60 Million | ▼ -1.0 pp |
| 2023 | 7.4% | $28.01 Million | $376.45 Million | ▼ -6.7 pp |
| 2022 | 14.1% | $60.96 Million | $430.84 Million | ▼ -13.9 pp |
| 2021 | 28.1% | $142.20 Million | $506.76 Million | — |